B.-G. Ericzon

938 citations
27 papers · 488 indexed · h-index 13

B.-G. Ericzon

25 papers receiving 473 citations

Peers

B.-G. Ericzon
Comparison fields: 5 of 66
  • Transplantation 97
  • Hepatology 124
  • Oncology 108
  • Surgery 167
  • Epidemiology 124
Replace A. Elli with:
A. Elli Italy
Diethelm Ag United States
A. Shaked United States
Bynvant Sandhu United Kingdom
H. Hedri Tunisia
L Meerman Netherlands
Luís Tomé Portugal
H. U. Klehr Germany
Révillard Jp France
A Yussim Israel
B.-G. Ericzon relative to A. Elli Italy A. Elli's profile →
Citations per field
00.5×10×13.5×
A. Elli · 1×
Citations per year

Countries citing papers authored by B.-G. Ericzon

Since Specialization
Citations

This map shows the geographic impact of B.-G. Ericzon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.-G. Ericzon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.-G. Ericzon more than expected).

Fields of papers citing papers by B.-G. Ericzon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.-G. Ericzon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.-G. Ericzon. The network helps show where B.-G. Ericzon may publish in the future.

Co-authorship network

The 25 scholars most cited alongside B.-G. Ericzon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with B.-G. Ericzon Line = papers co-authored together B.-G. Ericzon links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20211
2 20214
3 20196
4 201412
5 201211
6 201173
7
Report and recommendations from the 1st International Workshop on the Hereditary Renal Amyloidoses, FAP Symposium, London, 2008
20105
8 20101
9 199845
10
Renal transplant histopathologic changes during the first year in patients with tacrolimus (FK 506).
19961
11
Hepatic malignancies, a controversial indication for liver replacement: 10 year experience from a Scandinavian center.
19951
12 199531
13
Early graft function in liver transplantation patients.
19941
14
Improved quality of life after liver transplantation.
199415
15
New immunosuppressive drugs in transplantation.
199313
16 199213
17 19921
18 199013
19
Side effects of FK 506 in cynomolgus monkeys: a histopathologic study.
19904
20 198785

About B.-G. Ericzon

B.-G. Ericzon is a scholar working on Transplantation, Hepatology and Rheumatology, having authored 27 papers that have together received 488 indexed citations. Recurring topics across this work include Organ Transplantation Techniques and Outcomes (9 papers), Renal Transplantation Outcomes and Treatments (6 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers), Liver Disease Diagnosis and Treatment (4 papers), Liver Disease and Transplantation (4 papers), Clinical Nutrition and Gastroenterology (2 papers), Eosinophilic Disorders and Syndromes (2 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). The work is most often cited by research in Transplantation (97 citations), Hepatology (124 citations) and Oncology (108 citations). B.-G. Ericzon has collaborated with scholars based in Sweden, Belgium and United Kingdom. Frequent co-authors include H Wilczek, Markus Larsson, J Tollemar, Johan Andersson, Thomas E. Starzl, Igal Kam, K. Holmberg, David H. Van Thiel, Lorenzo Polimeno and Gregory W. Svanas. Their work appears in journals such as Amyloid, Transplantation, Journal of Hepatology, Transplant International and Mycoses.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026